Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.88 is 64% above its 5-year average of 4.19, near the high end of its 5-year range (0.75–7.91).
As of the fiscal period ended Tuesday, June 30, 2026. 60.43% above its 12-month average of 4.29.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.88.
CURRENT RATIO
6.88
CURRENT RATIO AVG TTM
4.29
CURRENT RATIO AVG 3Y
4.20
CURRENT RATIO AVG 5Y
4.19
CURRENT RATIO AVG 10Y
5.71
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+60.43%
CURRENT VS 3Y AVG
+63.85%
CURRENT VS 5Y AVG
+64.34%
CURRENT VS 10Y AVG
+20.44%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.38
median of 634 covered companies
CURRENT VS SECTOR MEDIAN
+103.86%
vs the sector median at left
Market Cap
$7.23M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.33M
Current Ratio
1.37
TTM Avg
4.18
3Y Avg
4.61
5Y Avg
4.18
Market Cap
$6.93M
Current Ratio
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.47
Market Cap
$6.92M
Current Ratio
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KALA BIO, Inc. (KALA) | $7.22M | 6.88 | 4.29 | 4.20 | 4.19 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.23M | 45.95 | 58.73 | 40.89 | 40.89 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.33M | 1.37 | 4.18 | 4.61 | 4.18 |
| Longeveron Inc. (LGVN)vs › | $7.33M | 2.63 | 4.46 | 3.65 | 4.69 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | 1.81 | 4.14 | 10.76 | 11.50 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.01M | 0.18 | 0.90 | 2.08 | 1.78 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.93M | 0.31 | 1.26 | 1.91 | 5.47 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.92M | 2.61 | 3.40 | 4.86 | 5.09 |
| Aclarion, Inc. (ACON)vs › | $6.70M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.67M | 10.21 | 3.61 | 3.34 | 4.20 |
Current Ratio
6.88
Quick Ratio
6.88
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.88 |
| 2026-03-31 | 7.91 |
| 2025-12-31 | 3.81 |
| 2025-09-30 | 0.75 |
| 2025-06-30 | 2.10 |
| 2025-03-31 | 1.99 |
| 2024-12-31 | 3.11 |
| 2024-09-30 | 2.15 |
| 2024-06-30 | 3.07 |
| 2024-03-31 | 4.22 |
| 2023-12-31 | 6.33 |
| 2023-09-30 | 5.62 |
| 2023-06-30 | 6.65 |
| 2023-03-31 | 6.95 |
| 2022-12-31 | 3.35 |
| 2022-09-30 | 2.10 |
| 2022-06-30 | 2.54 |
| 2022-03-31 | 3.00 |
| 2021-12-31 | 3.32 |
| 2021-09-30 | 5.48 |
| 2021-06-30 | 6.59 |
| 2021-03-31 | 8.96 |
| 2020-12-31 | 7.71 |
| 2020-09-30 | 9.11 |
| 2020-06-30 | 11.63 |
| 2020-03-31 | 12.17 |
| 2019-12-31 | 4.26 |
| 2019-09-30 | 6.25 |
| 2019-06-30 | 7.50 |
| 2019-03-31 | 10.30 |
| 2018-12-31 | 10.41 |
| 2018-09-30 | 6.34 |
| 2018-06-30 | 9.78 |
| 2018-03-31 | 20.40 |
| 2017-12-31 | 7.97 |
| 2017-09-30 | 10.99 |
| 2017-06-30 | 3.55 |
| 2017-03-31 | 5.42 |
| 2016-12-31 | 8.23 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 1.07 |
